Osteopore secures Thailand access targeting US$749M market
Full story: https://grafa.com/en/news/australia/osteopore-secures-thailand-access-targeting-us-749m-market
-
Osteopore secured market access in Thailand for its entire range of orthopaedic products.
-
The company partnered with integrated market management provider DCH Auriga to manage its local supply chain and logistics.
-
Thailand's orthopaedic devices market was valued at US$749 million in 2025 and is projected to reach US$1.5 billion by 2033.
Osteopore (ASX:OSX) secured market access in Thailand for its complete line of orthopaedic products to tap into a US$749 million regional market.
The market entry expands the medical device maker's reach into Thailand, where the local orthopaedic sector is projected to hit US$1.5 billion by 2033.
CEO Dr Yujing Lim said, "Our team has evaluated the potential of regional markets, and Thailand has been identified as one of our key markets in ASEAN."
To support the expansion, Osteopore established a supply chain and logistics partnership with healthcare market management provider DCH Auriga.
Following the announcement, the Osteopore share price was unchanged at $0.0050.
The Australian-Singaporean business specialises in 3D-printed bioresorbable implants designed to naturally rebuild bone tissue.
The Thai market access follows recent commercial distribution agreements and clinical trial milestones across Asia and the Middle East.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
